FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for Bromocriptine Mesylate, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Hyperprolactinemia
• Parkinson Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bromocriptine mesylate (bromocriptine mesylate)

Snippet

SUPPL AP for BROMOCRIPTINE MESYLATE (BROMOCRIPTINE MESYLATE)